Management & Regulatory

How Will A.I. Revolutionize Drug Discovery in the Pharmaceutical Industry?
Management & Regulatory How Will A.I. Revolutionize Drug Discovery in the Pharmaceutical Industry?

The rise of artificial intelligence (A.I.) in the pharmaceutical industry signifies a transformative period, placing unprecedented power in the hands of tech-driven drug discovery and igniting debates about innovation, control, and patient safety. Subject to regulatory scrutiny, the FDA has

How Will Advancements Shape the Global C-Arms Market by 2024?
Management & Regulatory How Will Advancements Shape the Global C-Arms Market by 2024?

The global C-arms market is on the cusp of significant transformation, driven by technological advancements and evolving healthcare needs. Valued at $2.21 billion in 2023, the market is projected to reach $2.35 billion in 2024, continuing its growth trajectory. This article delves into the key

Engineering Microbes for a Sustainable and Renewable Bioeconomy
Management & Regulatory Engineering Microbes for a Sustainable and Renewable Bioeconomy

In the quest for a sustainable future, the bioeconomy emerges as a significant solution, aiming to replace finite petrochemical resources with renewable resources produced by living organisms. This vision is driven by the need to create a circular economy where products and materials are fully

Global Cell Culture Vessels Market to Reach $19.65B by 2033
Management & Regulatory Global Cell Culture Vessels Market to Reach $19.65B by 2033

The global cell culture vessels market is on a remarkable growth trajectory, projected to expand from an estimated USD 4.90 billion in 2023 to over USD 19.65 billion by 2033. This significant growth, at a robust CAGR of 14.9% from 2024 to 2033, underscores the critical role of cell culture

Gene Therapy Investment Falls Post-COVID, Showing Future Hope
Management & Regulatory Gene Therapy Investment Falls Post-COVID, Showing Future Hope

The gene therapy sector, once a beacon of hope for revolutionary treatments, has seen a significant slowdown in investment post the COVID-19 pandemic. This downturn follows a period of unprecedented financial influx during the pandemic years, raising questions about the future of this promising

Widespread Layoffs in Biopharma: Economic and Strategic Challenges
Management & Regulatory Widespread Layoffs in Biopharma: Economic and Strategic Challenges

The biopharma industry, renowned for its rapid innovation and significant contributions to healthcare, currently faces a tumultuous period marked by widespread layoffs. From early 2023 through late 2024, numerous companies have announced substantial workforce reductions, which reflect a time of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later